|
|
| |
|
|
|
|
Contraceptive morbidity refers to morbidity
caused by use of specific contraceptives. Obviously, contraceptive
morbidity does not include the protective effects that
contraceptives have against a variety of adverse conditions, but
the concept of "contraceptive health" does include the
absence of these diseases, which include ovarian and endometrial
cancer, anemia, and STDs. Contraceptive morbidities are of 2 broad
types:
|
|
|
- Local effects of contraceptives include irritation from or
allergic reactions to barrier contraceptives, IUD-associated
bleeding, or infection at wound sites (implants, tubal
sterilisation).
- Systematic effects include impact on the cardiovascular and
hormonal systems and carcinogenicity (Fortney, 1995).
|
|
|
Ram and Rangaiyan (1997) studied the prevailing
contraceptive morbidity pattern among the contraceptive users by
method for all India and some selected states. They analysed the
NFHS-1 data and reviewed other available data for India and
different states (Karnataka, Madhya Pradesh, Maharashtra, Tamil
Nadu and Uttar Pradesh). The study indicate that a significant
proportion of women suffering from illness relate their problems
to contraceptive use. A comparatively higher proportion of
sterilised women had reportedly suffered illness related to
contraceptive use.
NFHS-2 provides information on the women who are using modern
contraceptive methods and reported problem with their method. 64%
of sterilised women and 81% of women whose husbands sterilised
report having no problems with their method. The most common
problems experienced by sterilised women are headache, body ache
or backache (23%), abdominal pain (15%), weakness or tiredness
(14%), white discharge (12%) and fever (5%). The results point to
a continuing need to strengthen postoperative care and counseling
for sterilisation acceptors. |
|
|
|
|
|
<<
BACK |
|
|
Updated by
Samatha Reddy
Dated: 18/08/2003 |
|
|
| |
|